1256379

Northwind Pharmaceuticals LLC — FEI 1831143

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed